For example, the cardiotoxic cancer drug ponatinib was found to activate the GCN2/eIF2α/Atf4 signaling axis in hiPSC-CMs and ISRIB was protective against cardiomyocyte death (123). Here, EIF2AK4 is linked to cancer.